Close Menu

NEW YORK (360Dx) – SQI Diagnostics today announced a technology development partnership and licensing agreement with the McMaster University department of engineering to develop chip technology for multi-array disease testing. 

Initial work has begun and the partners are currently further developing the chip technology and detection devices to enable a wide array of multi-result tests that will be offered directly in clinical settings, SQI said. It did not elaborate on what illnesses the tests will target. Financial and other details were also not disclosed. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.